175 related articles for article (PubMed ID: 20874654)
1. Immunotherapy in asthma.
Warrington R
Immunotherapy; 2010 Sep; 2(5):711-25. PubMed ID: 20874654
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in allergen immunotherapy.
Nouri-Aria KT
Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
[TBL] [Abstract][Full Text] [Related]
3. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells and asthma.
Robinson DS
Clin Exp Allergy; 2009 Sep; 39(9):1314-23. PubMed ID: 19538496
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of allergic inflammation in the lung by plasmid DNA allergen immunization.
Spiegelberg HL; Broide D; Tighe H; Roman M; Raz E
Pediatr Pulmonol Suppl; 1999; 18():118-21. PubMed ID: 10093118
[TBL] [Abstract][Full Text] [Related]
7. Treating moderate-to-severe allergic asthma with anti-IgE monoclonal antibody (omalizumab). An update.
D'Amato G; Perticone M; Bucchioni E; Salzillo A; D'Amato M; Liccardi G
Eur Ann Allergy Clin Immunol; 2010 Aug; 42(4):135-40. PubMed ID: 21114196
[TBL] [Abstract][Full Text] [Related]
8. Advances in upper airway diseases and allergen immunotherapy in 2007.
Saltoun C; Avila PC
J Allergy Clin Immunol; 2008 Sep; 122(3):481-7. PubMed ID: 18694591
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic asthma: not so different from allergic asthma but driven by superantigens?
Barnes PJ
Clin Exp Allergy; 2009 Aug; 39(8):1145-51. PubMed ID: 19538350
[TBL] [Abstract][Full Text] [Related]
10. Immunopathogenesis of bronchial asthma.
Buc M; Dzurilla M; Vrlik M; Bucova M
Arch Immunol Ther Exp (Warsz); 2009; 57(5):331-44. PubMed ID: 19688187
[TBL] [Abstract][Full Text] [Related]
11. The immunoglobulin E-Toll-like receptor network.
Novak N; Bieber T; Peng WM
Int Arch Allergy Immunol; 2010; 151(1):1-7. PubMed ID: 19672091
[TBL] [Abstract][Full Text] [Related]
12. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction.
Hessel EM; Chu M; Lizcano JO; Chang B; Herman N; Kell SA; Wills-Karp M; Coffman RL
J Exp Med; 2005 Dec; 202(11):1563-73. PubMed ID: 16314434
[TBL] [Abstract][Full Text] [Related]
13. [The role of IgE in allergic inflammation in asthma].
Chazan R
Wiad Lek; 2001; 54(5-6):337-43. PubMed ID: 11556217
[TBL] [Abstract][Full Text] [Related]
14. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity.
Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS
Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651
[TBL] [Abstract][Full Text] [Related]
15. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
16. Allergen immunotherapy: novel approaches in the management of allergic diseases and asthma.
Campbell D; DeKruyff RH; Umetsu DT
Clin Immunol; 2000 Dec; 97(3):193-202. PubMed ID: 11112358
[TBL] [Abstract][Full Text] [Related]
17. Allergen-related approaches to immunotherapy.
Rolland JM; Gardner LM; O'Hehir RE
Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
[TBL] [Abstract][Full Text] [Related]
18. [Specific immunotherapy in allergic asthma].
Bergmann KC
Pneumologie; 2003 Feb; 57(2):84-90. PubMed ID: 12579463
[TBL] [Abstract][Full Text] [Related]
19. [Immunomodulation therapy for allergic asthma. What is already possible, what is to come?].
Taube C; Buhl R
Dtsch Med Wochenschr; 2008 Apr; 133(14):727-32. PubMed ID: 18363195
[TBL] [Abstract][Full Text] [Related]
20. Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance.
von Hertzen LC; Savolainen J; Hannuksela M; Klaukka T; Lauerma A; Mäkelä MJ; Pekkanen J; Pietinalho A; Vaarala O; Valovirta E; Vartiainen E; Haahtela T
Allergy; 2009 May; 64(5):678-701. PubMed ID: 19383025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
